RaySearch secures distribution of RayStation® in Australia and New Zealand
ET | Source:RaySearch Laboratories AB
RaySearch Laboratories AB has entered into an exclusive distribution agreement
with AlphaXRT (formerly CMS Alphatech) based in Sydney, Australia and Auckland,
New Zealand. The agreement means that AlphaXRT will be fully responsible for
marketing, sales and service of RaySearch’s proprietary treatment planning
system RayStation® in Australia and New Zealand from April 1, 2014.
Australasia is a well-established, world renowned and growing radiation therapy
market. AlphaXRT is a leading distributor of software and equipment used in the
treatment of cancer and represents a wide range of respected international
suppliers. The company was founded in 1990 and the dedicated sales and support
team at AlphaXRT are highly experienced in the field of radiation therapy
treatment planning systems and serve all radiation therapy centres in Australia
and New Zealand.
“AlphaXRT is delighted to be representing RaySearch Laboratories in the
treatment planning market in Australasia. RaySearch have a longstanding
reputation in treatment planning solutions and RayStation® is the leading
independent treatment planning system available. We look forward to working with
RaySearch to promote RayStation® to our customers in the region”, says Richard
Neale, Managing Director of AlphaXRT.
“AlphaXRT is a leading distributor of advanced radiation therapy equipment with
a long track record, so we are of course delighted that they have elected to
partner with RaySearch. We will now work closely together with AlphaXRT’s
experienced experts to satisfy the needs of existing and future RayStation®
customers and I am fully convinced that this collaboration will be highly
fruitful for both companies”, says Johan Löf, CEO of RaySearch.
RayStation® integrates all RaySearch’s advanced treatment planning solutions
into a flexible treatment planning system. It combines unique features such as
multi-criteria optimization tools with full support for 4D adaptive radiation
therapy. It also includes functionality such as RaySearch’s market-leading
algorithms for IMRT and VMAT optimization and highly accurate dose engines for
photon, electron and proton therapy. The system is built on the latest software
architecture and has a graphical user interface offering state-of-the-art
RaySearch Laboratories is a medical technology company that develops advanced
software solutions for improved radiation therapy of cancer. RaySearch’s
products are mainly sold through license agreements with leading partners such
as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been
launched through partners and RaySearch’s software is used at over 2,300 clinics
in more than 30 countries. In addition, RaySearch offers the proprietary
treatment planning system RayStation® directly to clinics. RaySearch was founded
in 2000 as a spin-off from Karolinska Institutet in Stockholm and the company is
listed in the Small Cap segment on NASDAQ OMX Stockholm.
For more information about RaySearch, visit www.raysearchlabs.com
For further information, please contact:
Johan Löf, President and CEO, RaySearch Laboratories AB
Telephone: +46 (0)8-545 061 30
GlobeNewswire, a Nasdaq company, is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.